# Role Of Non-Specific Effects in The Treatment of Depression With Esketamine

> **NCT05910775** · NA · TERMINATED · sponsor: **Yale University** · enrollment: 1 (actual)

## Conditions studied

- Depressive Episode

## Interventions

- **BEHAVIORAL:** Pre and Post Treatment Presentations

## Key facts

- **NCT ID:** NCT05910775
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-07-13
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** The study was suspended due to challenges in recruiting a sufficient number of participants within a reasonable timeframe. Despite our efforts, enrollment did not meet the required threshold to proceed as planned.
- **Last updated:** 2026-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05910775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05910775, "Role Of Non-Specific Effects in The Treatment of Depression With Esketamine". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05910775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*